Bone mineral density in male patients with L-thyroxine suppressive therapy and graves disease

Calcified Tissue International

Volumn 69, Issue 2, 2001, Pages 84-87

  Jodar E ^a   Martinez Diaz Guerra G ^a   Azriel, S ^a   Hawkins, F ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Bone density; Bone metabolism; Hyperthyroidism; Levothyroxine suppressive therapy; Males

Indexed keywords

ALKALINE PHOSPHATASE; LEVOTHYROXINE; OSTEOCALCIN; PHOSPHORUS; THYROID HORMONE;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LUMBAR VERTEBRA; MALE; PRIORITY JOURNAL; THYROID CANCER; THYROID FUNCTION;

ADULT; BONE DENSITY; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; GRAVES DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; THYROID NEOPLASMS; THYROXINE;

EID: 0034890830     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230020041     Document Type: Article

References (24)

1. Morphometric and dynamic studies of bone changes in hyperthyroidism
2. Bone mineral density in patients with hyperthyroidism measured by dual X-ray absorptiometry
3. Risk factors for hip fracture in white women
4. Anti-resorptive therapy in hyperthyroid patients. Longitudinal changes in bone and mineral metabolism
5. Long-term thyroxine treatment and bone mineral density
6. Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis
7. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: A meta-analysis
8. Effects on bone mass of long-term treatment with thyroid hormones: A meta-analysis
9. Effect of hyperthyroidism and its treatment on bone mineral content
10. Thyroid hormone use and bone mineral density in elderly men
11. Bone mineral content in hypothyroid male patients with hormone replacement: A 3-year study
12. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine
13. Randomized trial of pamidronate in patients with thyroid cancer: Bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
14. Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis
15. Effect of calcitonin deficiency on bone density and bone turnover in totaly thyroidectomized patients
16. Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment
17. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: A risk of early osteopenia in postmenopausal women
18. Bone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment
19. Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans
20. Predictors of bone mass in perimenopausal women: A prospective study of clinical data using photon absorptiometry
21. National Osteoporosis Foundation Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis
22. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of etiology and menopause
23. Osteoporosis in men
24. The effect of thyroid hormone on skeletal integrity